CDMRP Amyotrophic Lateral Sclerosis (ALS) Therapeutic Idea Award
|קרן||US Department of Defense|
|פקולטה||Engineering, Exact Sciences, Life Sciences, Medicine|
The Therapeutic Idea Award is designed to promote new ideas aimed at drug, treatment, and target discovery that are still in the early stages of development. Proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve ALS treatment and/or advance a novel treatment modality.
It is expected that 17 grants will be awarded this year.
Funding: $500,000 total ($600,000 for Therapeutically Relevant Biomarker Option)
Duration: 2 years
Research Authority due date: 21.3.21
Pre application (required) due date: 9.4.21
Full application due date: 15.7.21
|עדכון אחרון||עדכון אחרון: 17/02/2021|